LLSC’s Pediatric Blood Cancer Research Innovation Grant – Letter of Intent
Academic Unit: inquire with unit
Memorial Deadline: Tuesday 25th, October 2022
External Deadline: Friday 28th, October 2022
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Pediatric Blood Cancer Research Innovation Grant Competition. This grant is designed to challenge the current pediatric blood cancer landscape by providing funding for projects that will address unmet needs for pediatric blood cancers.
In the current era of targeted and immuno-oncology drugs being developed in adults, very few successful examples have been translated to childhood blood cancer treatment. Clear advances have occurred, but cure rates remain low for certain blood cancer types, along with considerable long-term effects from traditional therapies. For the benefit of children, a better understanding of tumor biology and further progress in drug development and treatment are needed.
The LLSC’s Pediatric Blood Cancer Research Innovation Grant is a two-year grant designed to provide funding to research that will lead to a significant change in the understanding, diagnosis, or treatment of pediatric blood cancers.
The LLSC will provide funding for up to 5 grants up to a maximum of $100,000 per year for two years (up to a maximum total of $200,000 for the two years).
How to apply
The application process will occur in two phases.
Phase I – Submission and consideration of a Letter of Intent (LOI).
Phase II – Invitation to submit a Full Application.
Funds for competitive applications will be awarded on the basis of scientific merit, using a priority rating system.
- Letter of Intent (LOI) due – October 28, 2022, 4:00 pm (ET)
- Notification of Full Application Invite – Nov 2022
- Full application deadline – February 3, 2023, 4:00 pm (ET)
Additional detail’s can be found on the LLSC’s website.